Gordon B. Cutler

Active 1978–2024

Also published as
GORDON B. CUTLER
119
Papers
20,779
Citations
89
h-index
118
i10-index

Citations

Citations per year for Gordon B. Cutler1971: 1 citations1979: 2 citations1980: 4 citations1981: 6 citations1982: 9 citations1983: 14 citations1984: 20 citations1985: 33 citations1986: 51 citations1987: 48 citations1988: 61 citations1989: 54 citations1990: 73 citations1991: 91 citations1992: 65 citations1993: 87 citations1994: 121 citations1995: 107 citations1996: 152 citations1997: 134 citations1998: 174 citations1999: 192 citations2000: 187 citations2001: 166 citations2002: 243 citations2003: 156 citations2004: 142 citations2005: 191 citations2006: 146 citations2007: 142 citations2008: 137 citations2009: 129 citations2010: 92 citations2011: 163 citations2012: 98 citations2013: 95 citations2014: 121 citations2015: 100 citations2016: 105 citations2017: 64 citations2018: 62 citations2019: 257 citations2020: 221 citations2021: 161 citations2022: 81 citations2023: 49 citations2024: 114 citations2025: 67 citations1972–1978: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,854 citing papers, 37.9% of this breakdownUnited Kingdom: 357 citing papers, 7.3% of this breakdownItaly: 274 citing papers, 5.6% of this breakdownFrance: 225 citing papers, 4.6% of this breakdownGermany: 211 citing papers, 4.3% of this breakdownCanada: 189 citing papers, 3.9% of this breakdownNetherlands: 183 citing papers, 3.7% of this breakdownSweden: 121 citing papers, 2.5% of this breakdownJapan: 112 citing papers, 2.3% of this breakdownChina: 100 citing papers, 2% of this breakdownAustralia: 89 citing papers, 1.8% of this breakdownDenmark: 86 citing papers, 1.7% of this breakdown
0%37.9%Other 22.4%

Fields

  • Medicine62.2%
  • Biochemistry, Genetics and Molecular Biology17%
  • Neuroscience11.8%
  • Psychology4.5%
  • Health Professions0.9%
  • Environmental Science0.8%
  • Other2.8%

Topics

  • Growth Hormone and Insulin-like Growth Factors5.7%
  • Pituitary Gland Disorders and Treatments5.1%
  • Adrenal Hormones and Disorders4.9%
  • Stress Responses and Cortisol4.8%
  • Hypothalamic control of reproductive hormones4.7%
  • Sexual Differentiation and Disorders3.7%
  • Other71.1%

Coauthors

All papers

Open in search
  1. Phase 3 Trial of Crinecerfont in Adult Congenital Adrenal Hyperplasia

    Authors: , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2024 cited by 58

  2. Effects of Once Versus Twice-Daily Parathyroid Hormone 1–34 Therapy in Children with Hypoparathyroidism

    Authors: , , , , - The Journal of Clinical Endocrinology & Metabolism 2008 cited by 152

  3. Designing Randomized, Controlled Trials Aimed at Preventing or Delaying Functional Decline and Disability in Frail, Older Persons: A Consensus Report

    Authors: , , , , , , - Journal of the American Geriatrics Society 2004 cited by 1,029

  4. Petrosal Sinus Sampling with and without Corticotropin-Releasing Hormone for the Differential Diagnosis of Cushing's Syndrome

    Authors: , , , , , , , - New England Journal of Medicine 1991 cited by 874

  5. Long-Term Treatment of Hypoparathyroidism: A Randomized Controlled Study Comparing Parathyroid Hormone-(1–34)VersusCalcitriol and Calcium

    Authors: , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2003 cited by 307

  6. A Randomized, Cross-Over Trial of Once-Daily Versus Twice-Daily Parathyroid Hormone 1–34 in Treatment of Hypoparathyroidism

    Authors: , , , - The Journal of Clinical Endocrinology & Metabolism 1998 cited by 181

  7. Effects of Pump versus Twice-Daily Injection Delivery of Synthetic Parathyroid Hormone 1-34 in Children with Severe Congenital Hypoparathyroidism

    Authors: , , , - The Journal of Pediatrics 2014 cited by 123

  8. The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins.

    Authors: , , , , - The Journal of Clinical Endocrinology & Metabolism 1992 cited by 330

  9. Corrigenda

    Authors: , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2011 cited by 235

  10. Responses to Corticotropin-Releasing Hormone in the Hypercortisolism of Depression and Cushing's Disease

    Authors: , , , , , , , , , , , , , , - New England Journal of Medicine 1986 cited by 771

  11. Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.

    Authors: , , - 1996 cited by 147

  12. MBX 2109, A Once-Weekly Parathyroid Hormone Replacement Therapy Prodrug: Phase 1, First-In-Human, Randomized Trial

    Authors: , , , , - The Journal of Clinical Endocrinology & Metabolism 2024 cited by 13

  13. A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty

    Authors: , , , , , - Nature 1993 cited by 758

  14. Cushing's Syndrome in Children and Adolescents - Presentation, Diagnosis, and Therapy

    Authors: , , , , , , , - New England Journal of Medicine 1994 cited by 433

  15. Increased Final Height in Precocious Puberty after Long-Term Treatment with LHRH Agonists: The National Institutes of Health Experience

    Authors: , , , , - The Journal of Clinical Endocrinology & Metabolism 2001 cited by 205

  16. Flutamide, Testolactone, and Reduced Hydrocortisone Dose Maintain Normal Growth Velocity and Bone Maturation Despite Elevated Androgen Levels in Children with Congenital Adrenal Hyperplasia

    Authors: , , , , , - The Journal of Clinical Endocrinology & Metabolism 2000 cited by 183

  17. Treatment with a Luteinizing Hormone–Releasing Hormone Agonist in Adolescents with Short Stature

    Authors: , , , , , , - New England Journal of Medicine 2003 cited by 152

  18. Therapy with PTH 1–34 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27 years at a single tertiary care center

    Authors: , , , , , , - Bone 2021 cited by 29

  19. Gonadotropin Secretory Dynamics During Puberty in Normal Girls and Boys

    Authors: , , , , - The Journal of Clinical Endocrinology & Metabolism 1990 cited by 257

  20. A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome.

    Authors: , , , , , - The Journal of Clinical Endocrinology & Metabolism 1993 cited by 219

  21. Growth Hormone plus Childhood Low-Dose Estrogen in Turner's Syndrome

    Authors: , , , , , , - New England Journal of Medicine 2011 cited by 211

  22. Early repeat surgery for persistent Cushing's disease

    Authors: , , , , , - Journal of neurosurgery 1994 cited by 201

  23. A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia

    Authors: , , , , , , , , , , - Human Molecular Genetics 1995 cited by 136

  24. Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome.

    Authors: , , , , - 1990 cited by 80